Biotech · Private company · Cambridge, MA, US
Dna Medicine Institute
Track this companyFree. Adds Dna Medicine Institute to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards7
- TABA Supplement for Hemophilia Point-of-Care DeviceFiscal year 2026 · $50KNIH RePORTER 3R44HL151147-05S1 · fetched Nov 12, 2026
- Hemophilia Point-of-Care Monitoring Device and AppFiscal year 2026 · $1MNIH RePORTER 5R44HL151147-05 · fetched Nov 12, 2026
- 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient ManagementFiscal year 2025 · $50KNIH RePORTER 3R44HL170817-01A1S1 · fetched Nov 12, 2026
- Hemophilia Point-of-Care Monitoring Device and AppFiscal year 2025 · $1MNIH RePORTER 5R44HL151147-04 · fetched Nov 12, 2026
- 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient ManagementFiscal year 2025 · $1MNIH RePORTER 5R44HL170817-02 · fetched Nov 12, 2026
- 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient ManagementFiscal year 2024 · $1MNIH RePORTER 1R44HL170817-01A1 · fetched Nov 12, 2026
- Hemophilia Point-of-Care Monitoring Device and AppFiscal year 2024 · $999.9KNIH RePORTER 2R44HL151147-03 · fetched Nov 12, 2026